Allogene Therapeutics shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Allogene Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Allogene Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Allogene Therapeutics by Rhumbline Advisers
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $469k | 146k | 3.21 |
2023-09-30 | $441k | 139k | 3.17 |
2023-06-30 | $717k | 144k | 4.97 |
2023-03-31 | $638k | 129k | 4.94 |
2022-12-31 | $789k | 126k | 6.29 |
2022-09-30 | $1.4M | 129k | 10.80 |
2022-06-30 | $1.4M | 119k | 11.40 |
2022-03-31 | $769k | 84k | 9.11 |
2021-12-31 | $1.3M | 90k | 14.92 |
2021-09-30 | $2.3M | 91k | 25.70 |
2021-06-30 | $2.3M | 88k | 26.08 |
2021-03-31 | $2.2M | 61k | 35.30 |
2020-12-31 | $1.7M | 67k | 25.24 |
2020-09-30 | $2.4M | 64k | 37.72 |
2020-06-30 | $3.3M | 76k | 42.82 |
2020-03-31 | $1.1M | 55k | 19.44 |
2019-12-31 | $1.4M | 53k | 25.98 |
2019-09-30 | $1.4M | 51k | 27.25 |
2019-06-30 | $1.4M | 51k | 26.85 |
2019-03-31 | $906k | 31k | 28.90 |
2018-12-31 | $829k | 31k | 26.93 |